Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Updates on clinical trials evaluating the regenerative potential of allogenic mesenchymal stem cells in COVID-19
Dhavan Sharma, Feng Zhao
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Mesenchymal Stem Cell-Derived Extracellular Vesicles in Liver Immunity and Therapy
Ruiqi Wu, Xiaoli Fan, Yi Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 67
Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial
Cármen Lúcia Kuniyoshi Rebelatto, Alexandra Cristina Senegaglia, Cláudio Luciano Franck, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections
Yizhuo Wang, Shuyun Liu, Lan Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 118-132
Open Access | Times Cited: 41
Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects
Vamika Karn, Shaista Ahmed, Lung‐Wen Tsai, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1373-1373
Open Access | Times Cited: 50
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment
Hamid Reza Aghayan, Fatemeh Salimian, Atefeh Abedini, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Hypoxic ASCs-derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization via miR-216a-5p/HMGB1 Axis
Wenwei Qian, Liangyu Huang, Yihan Xu, et al.
Inflammatory Bowel Diseases (2022) Vol. 29, Iss. 4, pp. 602-619
Closed Access | Times Cited: 31
Mesenchymal stromal cells derived from various tissues: Biological, clinical and cryopreservation aspects: Update from 2015 review
Leah A. Marquez‐Curtis, Janet A.W. Elliott
Cryobiology (2024) Vol. 115, pp. 104856-104856
Open Access | Times Cited: 3
Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signature
Abantika Ganguly, G. Jawahar Swaminathan, Fernando Jose Garcia-Marques, et al.
Stem Cell Reports (2022) Vol. 18, Iss. 1, pp. 190-204
Open Access | Times Cited: 16
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
Aidan M. Kirkham, Adrian Bailey, Risa Shorr, et al.
Cytotherapy (2022) Vol. 25, Iss. 3, pp. 341-352
Open Access | Times Cited: 14
Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies
Sarah Hamdy Ahmed, Mohamed Atef AlMoslemany, Kenneth W. Witwer, et al.
Stem Cell Reviews and Reports (2024) Vol. 20, Iss. 4, pp. 900-930
Open Access | Times Cited: 2
Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
Mattia Emanuela Ligotti, Fanny Pojero, Giulia Accardi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 15
Ethical issues and public communication in the development of cell-based treatments for COVID-19: Lessons from the pandemic
Leigh Turner, Megan Munsie, Aaron Levine, et al.
Stem Cell Reports (2021) Vol. 16, Iss. 11, pp. 2567-2576
Open Access | Times Cited: 13
Immunomodulation and Regenerative Capacity of MSCs for Long-COVID
Xin Ya Loke, Siti A. M. Imran, Gee Jun Tye, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12421-12421
Open Access | Times Cited: 13
New Treatments (MSC) in Immune Disorders Like Cancers and Covid Infection: Cancer and Virus New Treatment (MSC )
Nadia Ghasemi Darestani, Soheyla Hashemi, Zahra Rahimi, et al.
Asian Pacific Journal of Cancer Biology (2024) Vol. 9, Iss. 2, pp. 257-261
Open Access | Times Cited: 1
Restoration of vascular endothelial integrity by mesenchymal stromal/stem cells in debilitating virus diseases
Agieshkumar Balakrishna Pillai, Vignesh Mariappan, Aashika Raagavi JeanPierre, et al.
Human Cell (2022) Vol. 35, Iss. 6, pp. 1633-1639
Open Access | Times Cited: 8
In silico study of novel niclosamide derivatives, SARS-CoV-2 nonstructural proteins catalytic residue-targeting small molecules drug candidates
Bashir Lawal, Sheng-Kuang Tsai, Alexander T.H. Wu, et al.
Arabian Journal of Chemistry (2023) Vol. 16, Iss. 5, pp. 104654-104654
Open Access | Times Cited: 4
Feasibility Study of Cord Tissue Derived Mesenchymal Stromal Cells in COVID-19-Related Acute Respiratory Distress Syndrome
Beth H. Shaz, Bryan Kraft, Jesse D. Troy, et al.
Stem Cells Translational Medicine (2023) Vol. 12, Iss. 4, pp. 185-193
Open Access | Times Cited: 4
Ascorbic acid and IFNγ preconditioning enhance the potency of human mesenchymal stem cells to ameliorate LPS induced cytokine storm
Avinash Sanap, Supriya Kheur, Avinash Kharat, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110643-110643
Closed Access | Times Cited: 4
Perfusability and immunogenicity of implantable pre-vascularized tissues recapitulating features of native capillary network
Dhavan Sharma, Archita Sharma, Linghao Hu, et al.
Bioactive Materials (2023) Vol. 30, pp. 184-199
Open Access | Times Cited: 4
Mesenchymal stromal cell delivery as a potential therapeutic strategy against COVID-19: Promising evidence from in vitro results
Panagiotis Mallis, Theofanis Chatzistamatiou, Zetta Dimou, et al.
World Journal of Biological Chemistry (2022) Vol. 13, Iss. 2, pp. 47-65
Open Access | Times Cited: 7
Investigating the Immunomodulatory Potential of Dental Pulp Stem Cell Cultured on Decellularized Bladder Hydrogel towards Macrophage Response In Vitro
Huynh-Quang-Dieu Nguyen, Chen‐Yu Kao, Chien‐Ping Chiang, et al.
Gels (2022) Vol. 8, Iss. 3, pp. 187-187
Open Access | Times Cited: 5
Mesenchymal Stem Cell Treatment for Hyperactive Immune Response in Patients with COVID-19
Ragul Manoharan, Rajshekhar A. Kore, Jawahar L. Mehta
Immunotherapy (2022) Vol. 14, Iss. 13, pp. 1055-1065
Open Access | Times Cited: 5
Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19
Greg Maguire
Communicative & Integrative Biology (2021) Vol. 14, Iss. 1, pp. 186-198
Open Access | Times Cited: 6
Current Landscape of Mesenchymal Stem Cell Therapy in COVID Induced Acute Respiratory Distress Syndrome
Adrita Chanda, Adrija Aich, Arka Sanyal, et al.
ACTA SCIENTIFIC MICROBIOLOGY (2022), pp. 149-162
Open Access | Times Cited: 4
Tissue engineering application on coronavirus (Covid-19) Pandemic: A review
Saeedeh Zare Jalise, Sina Habibi
Afghanistan Journal of Infectious Diseases (2024) Vol. 2, Iss. 1, pp. 41-50
Open Access
Page 1 - Next Page

Scroll to top